As of September 09, 2026, Protalix BioTherapeutics's top three insider holders are Dror Bashan (President And Ceo, 2.34Mn shares), Eyal Rubin (Sr. Vp And Cfo, 660.91K shares), Eyal Rubin (Sr. Vp And Cfo, 660.91K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Eyal Rubin | Sr. Vp And Cfo | 0 | 660,909 | 660,909 | 56.8% | 05 Nov, 2024 |
| 2 | Yaron Naos | Sr. Vp, Operations | 0 | 225,817 | 225,817 | 19.4% | 04 Sep, 2025 |
| 3 | Dror Bashan | President And Ceo | 188,516 | 0 | 188,516 | 16.2% | 23 Dec, 2025 |
| 4 | Yael Hayon | Vp, Research Development | 0 | 35,115 | 35,115 | 3.0% | 17 Aug, 2023 |
| 5 | Eliot Forster | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 6 | Zvi Shmuel Ben | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 7 | Amos Bar-Shalev | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 8 | Christian Elze | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 9 | Pol F Boudes | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 10 | Gwen A Melincoff | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 11 | Aharon Schwartz | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 03 Sep, 2026 | Pol F Boudes | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Dror Bashan | President And Ceo | Acquired A | 320,000 | $0.00 | $0 | 320,000 | Direct |
| 03 Sep, 2026 | Christian Elze | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Dror Bashan | President And Ceo | Acquired A | 160,000 | $0.00 | $0 | 160,000 | Direct |
| 03 Sep, 2026 | Pol F Boudes | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Christian Elze | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Gwen A Melincoff | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Zvi Shmuel Ben | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Eliot Forster | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Yaron Naos | Sr. Vp Coo | Acquired A | 112,000 | $0.00 | $0 | 112,000 | Direct |
| 03 Sep, 2026 | Eliot Forster | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Gwen A Melincoff | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Zvi Shmuel Ben | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Yaron Naos | Sr. Vp Coo | Acquired A | 56,000 | $0.00 | $0 | 56,000 | Direct |
| 03 Sep, 2026 | Amos Bar-Shalev | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Amos Bar-Shalev | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 19 Dec, 2025 | Dror Bashan | President And Ceo | Acquired P | 56,000 | $1.81 | $101.36K | 188,516 | Direct |
| 18 Nov, 2025 | Amos Bar-Shalev | Director | Disposed S | 168 | $1.87 | $314 | 0 | Direct |
| 03 Sep, 2025 | Amos Bar-Shalev | Director | Acquired A | 7,500 | — | — | 7,500 | Indirect |
| 03 Sep, 2025 | Eliot Forster | Director | Acquired A | 7,500 | — | — | 7,500 | Indirect |